Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Department of Health and Human Services
At a glance
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) is an open federal grant opportunity from the Food and Drug Administration (Department of Health and Human Services). Applications are due February 8, 2028. Individual awards are listed as up to $600K. Applicant types listed as eligible include others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Jul 11, 2025
- Close date
- Feb 8, 2028
- Archive date
- Mar 9, 2028
- Award floor
- Not specified
- Award ceiling
- $600,000
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Who can apply
- Others (see notice)
Additional information on eligibility (from the notice)
Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)Local GovernmentsState GovernmentsCounty GovernmentsCity or Township GovernmentsSpecial District GovernmentsIndian/Native American Tribal Governments (Federally Recognized)Indian/Native American Tribal Governments (Other than Federally Recognized)Federal Governments U.S. Territory or PossessionOtherIndependent School DistrictsPublic Housing Authorities/Indian Housing AuthoritiesNative American Tribal Organizations (other than Federally recognized tribal governments)Faith-based or Community-based OrganizationsRegional OrganizationsNon-domestic (non-U.S.) Entities (Foreign Organizations)Foreign OrganizationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Assistance Listing
What is an ALN?Reported obligations under ALN 93.103
Historical data · not a predictionAgency contact (as published)
Stephanie Bogan Grantor
Kimberly.Pendleton@fda.hhs.gov
3018276802
Quick answers
When is the deadline for this opportunity?
According to the official notice, applications are due February 8, 2028. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: Others (see notice). Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as up to $600k.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-FD-25-017), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration- Award range
- Up to $250K
- Closes
- Jan 29, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration- Award range
- Up to $200K
- Closes
- Apr 1, 2027
- Who can apply
- Others (see notice)
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration- Award range
- Up to $1.25M
- Closes
- May 12, 2028
- Who can apply
- Public colleges & universities, Private colleges & universities and Others (see notice)
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration- Award range
- Up to $900K
- Closes
- May 16, 2028
- Who can apply
- Others (see notice)
Retail Food Safety Regulatory Association Collaboration
Food and Drug Administration- Award range
- Amount not specified
- Est. close
- Not yet set
- Who can apply
- Others (see notice)
FDA's Integrated Food Safety System Training Delivery and Development
Food and Drug Administration- Award range
- Amount not specified
- Est. close
- Not yet set
- Who can apply
- Others (see notice)